Thrivent All Cap Portfolio ABBV Holdings History
Thrivent All Cap Portfolio's AbbVie Inc Holding Summary
As of 2025-03-31, THRIVENT SERIES FUND INC held 5,107.00 shares of AbbVie Inc(ABBV), totaling $1.07 Mil. This investment constitutes 0.6% of their stock portfolio, and THRIVENT SERIES FUND INC now holds 0% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2021Q2. And since then Thrivent All Cap Portfolio has made 3 purchases of ABBV, at an average price of $139.32, for a total of 15,837.00 shares. In addition, there have been 2 sales at an average price of $151.34 for 10,730.00 shares. Based on historical transaction data and ABBV's current price of $190.91, Thrivent All Cap Portfolio's estimated gain on his ABBV holdings is $392,337.04, reflecting a 17.78% gain to date.
Thrivent All Cap Portfolio ABBV ($190.91) Holding Chart
Thrivent All Cap Portfolio ABBV ($190.91) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
